Allogenic

Eyestem Announces US Operations With The Appointment Of Ravi Achar

24/02/2023

The company is laying the groundwork for its global expansion through partnerships and strategic alliances for its flagship product, Eyecyte-RPE, an experimental treatment for Dry Age-Related Macular Degeneration